Revolutionizing Pediatric Care: Approval of Mal...

By João L. Carapinha

July 10, 2025

Novartis recently announced that it has received approval for the first malaria medicine for newborns, specifically developed for babies and young infants. This groundbreaking development targets a vulnerable population that has historically had l...
Talquetamab Multiple Myeloma: Impact, Evidence, and Policy Considerations
Masitinib Prostate Cancer Trial Gains FDA and EMA Approval for Phase 3 Study
BEBT-908 DLBCL Treatment: A Milestone Approval for a First-in-Class Dual Inhi...
AI Clinician in Pediatric ICU: A Review and HEOR Perspective
EU Life Sciences Strategy: Paving the Way for Europe’s Leadership by 2030
Pharma Ad Spending Trends: Insights from the Top 10 Drug Advertisers of 2024
How Does Mind’s AI-Driven Mental Healthcare Transform Care?
Cell Therapy for Type 1 Diabetes: Vertex Trial Results and Market Potential
ACIP Vaccine Policy Concerns
NICE Rejects Donanemab: Treatment Cost-Effectiveness
How Gene-Editing Therapies Are Revolutionizing ASCVD Treatment and Market Tra...
EMA 2024 Report Highlights: Innovations in Medicine Approval and Regulatory A...